학술논문

Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Document Type
Article
Source
International Journal of Gynecological Cancer; Apr2023, Vol. 33 Issue 4, p562-570, 9p
Subject
Language
ISSN
1048891X